Monopar Therapeutics Inc.
MNPRNASDAQ
Healthcare
Biotechnology
$53.30
-1.83(-3.3%)
52W $28.89 – $102.05
Quick:
10-K/A
Apr 1, 2026 (5 days ago)Annual Report (Amendment)
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Mar 27, 2026 (1 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 2, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Feb 17, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Feb 6, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13D/A
Jan 30, 2026 (2 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
SCHEDULE 13G/A
Nov 14, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Nov 14, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Nov 13, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 13, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Nov 10, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Sep 24, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13D/A
Sep 24, 2025 (6 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Sep 15, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Aug 14, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Aug 12, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Aug 12, 2025 (7 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Jun 23, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
May 14, 2025 (10 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
May 13, 2025 (10 months ago)Current Report
Material event disclosure
Event materiality and market reaction